| ADO | adenosine |
| ADSCs | adipose-derived mesenchymal stromal cells |
| AK1 | adenylate kinase isoenzyme 1 |
| ANK | ankylosis protein |
| AR-A1R-A2AR-A2BR-A3R | Adenosine, A1, A2A, A2B, A3 receptors |
| BzATP | 2’(3’)-O-(4-Benzoylbenzoyl)adenosine-5’-triphosphate |
| CD38 | ADP-ribosyl cyclase 1 |
| CD73 | ecto-5′nucleotidase |
| CDK | chronic kidney disease |
| DAMPs | damage-associated molecular patterns |
| e-ADA | extracellular adenosine deaminase |
| ECM | extracellular matrix |
| ENPP | ectonucleotide pyrophosphatase/phosphodiesterase |
| HA | hydroxyapatite |
| HPP | hypophosphatasia |
| KO | knockout |
| MSCs | mesenchymal stem cells |
| MVs | matrix vesicles |
| NAD+ | nicotinamide adenine dinucleotide |
| NDPK | nucleoside diphosphokinase |
| NTPDases | ectonucleoside triphosphate diphosphohydrolases |
| P2 × 1R-P2 × 7R-P2Y2R-P2Y6R, P2Y13R, P2Y14R | P2 × 1, P2 × 7, P2Y2, P2Y6, P2Y13, P2Y14 receptors |
| PAP | prostatic acid phosphatase |
| Pi | inorganic phosphate |
| PNP | purine nucleoside phosphorylase |
| PPi | inorganic pyrophosphate |
| RA | rheumatoid arthritis |
| RANKL | receptor activator of nuclear factor kB ligand |
| SCI | severe combined immunodeficiency |
| TNAP | tissue nonspecific alkaline phosphatase |
| VNUT | vesicular nucleotide transporter |